These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 11371029)
1. Expression of MIB and BCL-2 in patients with nephrogenic rests with and without associated Wilms' tumors. Wünsch L; Flemming P; Glüer S Eur J Pediatr Surg; 2001 Apr; 11(2):105-9. PubMed ID: 11371029 [TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma. Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Van den Heuvel MM; Noordzij MA; Nijman RJ; Soliman EH; van Steenbrugge GJ Br J Cancer; 2001 Nov; 85(10):1557-63. PubMed ID: 11720445 [TBL] [Abstract][Full Text] [Related]
4. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor. Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629 [TBL] [Abstract][Full Text] [Related]
5. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway. Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125 [TBL] [Abstract][Full Text] [Related]
6. Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas. Guertl B; Ratschek M; Harms D; Jaenig U; Leuschner I; Poremba C; Hoefler G Hum Pathol; 2003 Mar; 34(3):278-81. PubMed ID: 12673563 [TBL] [Abstract][Full Text] [Related]
7. Expression and localization of HGF and met in Wilms' tumours. Alami J; Williams BR; Yeger H J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645 [TBL] [Abstract][Full Text] [Related]
8. Expression of apoptosis, cell proliferation, and drug resistance genes in pediatric Wilms' tumors. Ramachandran C; Melnick SJ; Escalon E; Jhabvala P; Khatib Z; Alamo A; Smith S Anticancer Res; 2000; 20(5C):3759-65. PubMed ID: 11268451 [TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma. Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242 [TBL] [Abstract][Full Text] [Related]
10. Expression of WT-1, Bcl-2, and CD34 by primary renal spindle cell tumors in children. Shao L; Hill DA; Perlman EJ Pediatr Dev Pathol; 2004; 7(6):577-82. PubMed ID: 15630525 [TBL] [Abstract][Full Text] [Related]
11. Precursor lesions of Wilms' tumor in Indian children: a multiinstitutional study. Mishra K; Mathur M; Logani KB; Kakkar N; Krishna A Cancer; 1998 Nov; 83(10):2228-32. PubMed ID: 9827730 [TBL] [Abstract][Full Text] [Related]
12. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644 [TBL] [Abstract][Full Text] [Related]
13. Expression of apoptosis-related antigens, Fas, bcl-2, and p53, and Mib-1 proliferation index in the hypoplastic thymus of DiGeorge syndrome. Zhou H; Perkins SL; Tripp S; Hussong JW; Coffin CM Pediatr Dev Pathol; 2002; 5(5):465-71. PubMed ID: 12202998 [TBL] [Abstract][Full Text] [Related]
14. Perilobar nephrogenic rests and chromosome 22. Mdzin R; Phillips M; Edwards C; Murch A; Charles A Pediatr Dev Pathol; 2011; 14(6):485-92. PubMed ID: 21864120 [TBL] [Abstract][Full Text] [Related]
15. Tumour cell proliferation rate as determined by MIB-1 antibody in Wilms' tumour. Juszkiewicz P; Tuziak T; Zbisławski W; Liebhard M; Chosia M Pol J Pathol; 1997; 48(2):113-9. PubMed ID: 9278108 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of neural cell adhesion molecule in Wilms tumors, nephrogenic rests, and fetal and postnatal renal cortices. Kapur P; Rakheja D Pediatr Dev Pathol; 2011; 14(1):16-9. PubMed ID: 20524836 [TBL] [Abstract][Full Text] [Related]
17. Different proliferative patterns characterize different preinvasive breast lesions. Viacava P; Naccarato AG; Bevilacqua G J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590 [TBL] [Abstract][Full Text] [Related]
18. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer. Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413 [TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology. Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575 [TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical evaluation of the percentage of proliferating neoplastic cells of Wilms' tumor in children by means of the MIB-1 monoclonal antibody]. Juszkiewicz P Ann Acad Med Stetin; 1997; 43():113-27. PubMed ID: 9471911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]